Kiora Pharmaceuticals, Inc.

0.57 USD
-0.00 (-0.78%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Kiora Pharmaceuticals, Inc. stock is up 16.33% since 30 days ago. The next earnings date is Jun 4, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 9 May’s closed higher than April. 100% of analysts rate it a buy.

About Kiora Pharmaceuticals, Inc.

Kiora Pharmaceuticals, Inc. develops and commercializes therapies for the treatment of ophthalmic diseases in the United States. Its lead product is KIO-301, a potential vision-restoring small molecule that acts as a photoswitch to restore vision in patients with inherited and age-related degenerative retinal diseases.